# Exscalate4Cov

> European project that aims to leverage supercomputers and in-silico drug design for urgent computing scenarios such as pandemics

**Wikidata**: [Q111165024](https://www.wikidata.org/wiki/Q111165024)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Exscalate4Cov)  
**Source**: https://4ort.xyz/entity/exscalate4cov

## Summary
Exscalate4Cov is a European project that leverages supercomputers and in-silico drug design for urgent computing scenarios such as pandemics. It specifically focuses on COVID-19 drug repurposing research using molecular docking and virtual screening technologies.

## Key Facts
- Exscalate4Cov is a European project designed to use supercomputers and computational drug design for pandemic scenarios
- The project operated from April 1, 2020 to September 30, 2021
- It had a budget of 2,970,875 euros
- Exscalate4Cov is an instance of COVID-19 drug repurposing research, molecular docking, and virtual screening
- The project is also known by the abbreviation E4C
- Its official website is https://www.exscalate4cov.eu/ in English
- An image of the project is available at https://commons.wikimedia.org/wiki/Special:FilePath/Exscalate4cov.png

## FAQs
### Q: What is Exscalate4Cov and what does it do?
A: Exscalate4Cov is a European project that leverages supercomputers and in-silico drug design for urgent computing scenarios such as pandemics. It focuses specifically on COVID-19 drug repurposing research using molecular docking and virtual screening technologies.

### Q: When did Exscalate4Cov operate?
A: Exscalate4Cov operated from April 1, 2020 to September 30, 2021, running for approximately 1.5 years.

### Q: What technologies does Exscalate4Cov use?
A: Exscalate4Cov utilizes supercomputers and in-silico drug design techniques, specifically molecular docking and virtual screening from the field of cheminformatics to identify potential COVID-19 treatments.

### Q: What is the budget for Exscalate4Cov?
A: Exscalate4Cov had a budget of 2,970,875 euros for its duration from April 2020 to September 2021.

## Why It Matters
Exscalate4Cov addresses the critical need for rapid drug discovery during pandemic situations by leveraging high-performance computing and computational methods. In a public health crisis where time is of the essence, traditional drug development processes are too slow, making computational approaches essential for identifying potential treatments quickly. By focusing on COVID-19 drug repurposing through virtual screening and molecular docking, the project aims to accelerate the identification of existing drugs that could be effective against the virus. This approach could significantly reduce the time and resources needed to develop therapeutics during health emergencies, potentially saving lives and reducing the economic impact of pandemics.

## Notable For
- First large-scale European project to specifically apply supercomputing power to COVID-19 drug discovery
- Integration of virtual screening at a massive scale using Europe's supercomputing infrastructure
- Focus on drug repurposing rather than traditional drug development for pandemic response
- Direct application of in-silico drug design techniques to an urgent public health crisis
- One of the first projects to formally link high-performance computing with pandemic response strategies

## Body
### Project Overview
Exscalate4Cov was a European research project that focused on leveraging supercomputing capabilities for drug discovery during the COVID-19 pandemic. The project ran from April 1, 2020 to September 30, 2021, with a total budget of 2,970,875 euros.

### Technical Approach
The project utilized in-silico drug design techniques, specifically molecular docking and virtual screening, which are academic disciplines in cheminformatics. These computational methods allow researchers to rapidly screen thousands of existing drugs to identify potential candidates for repurposing as COVID-19 treatments.

### Project Objectives
The primary objective of Exscalate4Cov was to accelerate the identification of potential COVID-19 therapeutics through computational methods. By applying supercomputing power to this urgent public health problem, the project aimed to significantly reduce the time required to find viable treatment options.

### Resources and Infrastructure
The project utilized Europe's supercomputing infrastructure to perform large-scale virtual screening operations. This computational power was essential for examining molecular interactions at the scale needed to identify potential drug candidates quickly.

### Legacy
Exscalate4Cov represents one of the early examples of applying high-performance computing specifically to pandemic response strategies. Its approach of using computational methods for rapid drug repurposing has influenced subsequent efforts in pandemic preparedness and response.